Palliative care experience and perceived gaps in training among transplant hepatology fellows: A national survey

Maureen P. Whitsett, Nneka N. Ufere, Arpan Patel, Judy A. Shea, Christopher A. Jones, Oren K. Fix, Marina Serper – 10 April 2022 – Despite the likely benefits of palliative care (PC) for patients with cirrhosis, physician experiences and perspectives about best practices are variable. We aimed to assess PC experience and gaps in training among transplant hepatology fellows. We conducted a national survey of all transplant hepatology fellows enrolled in accredited fellowship programs during the 2020–2021 academic year.

Beneficial effect of ursodeoxycholic acid in patients with acyl‐CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia

Marta Alonso‐Peña, Ricardo Espinosa‐Escudero, Elisa Herraez, Oscar Briz, Maria Luisa Cagigal, Jesus M. Gonzalez‐Santiago, Aida Ortega‐Alonso, Conrado Fernandez‐Rodriguez, Luis Bujanda, Marta Calvo Sanchez, Delia D´Avola, Maria‐Carlota Londoño, Moises Diago, Jose C. Fernandez‐Checa, Carmen Garcia‐Ruiz, Raul J. Andrade, Frank Lammert, Jesus Prieto, Javier Crespo, Javier Juamperez, Alvaro Diaz‐Gonzalez, Maria J. Monte, Jose J. G. Marin – 7 April 2022

Operational tolerance is not always permanent: A 10‐year prospective study in pediatric liver transplantation recipients

Laura J. Wozniak, Robert S. Venick, Bita V. Naini, Jason Scapa, Michelle J. Hickey, Maura Rossetti, Yael Korin, Elaine F. Reed, Douglas G. Farmer, Ronald W. Busuttil, Jorge H. Vargas, Sue V. McDiarmid – 7 April 2022 – Immunosuppression withdrawal can be safely performed in select liver transplantation recipients, but the long‐term outcomes and sustainability of tolerance have not been well studied.

Subscribe to